Mevastatin
SIGMA/M2537 - ≥98% (HPLC), powder or crystals
Synonym: Compactin; ML-236B
CAS Number: 73573-88-3
Empirical Formula (Hill Notation): C23H34O5
Molecular Weight: 390.51
MDL Number: MFCD05662341
Linear Formula: C23H34O5
Product Type: Chemical
| antibiotic activity spectrum | neoplastics |
| assay | ≥98% (HPLC) |
| color | white to light yellow |
| form | powder or crystals |
| InChI | 1S/C23H34O5/c1-4-14(2)23( |
| InChI key | AJLFOPYRIVGYMJ-INTXDZFKSA |
| mode of action | enzyme | inhibits |
| mp | 151 °C |
| originator | Daiichi-Sankyo |
| Quality Level | 200 ![]() |
| SMILES string | [H][C@]12[C@H](CCC=C1C=C[ |
| solubility | ethanol: 25-26 mg/mL, clear, colorless |
| storage temp. | 2-8°C |
| Application: | Mevastatin has been used: • to analyze its effects on chronic lymphocytic leukemia (CLL) cells by cytotoxic assay • as a prenylation inhibitor to analyze its effects on human embryonic kidney (HEK) cells transfected with K-Ras • as a statin agent to study its anti-cancer effect on human breast cancer cells and glioblastoma in vitro |
| Biochem/physiol Actions: | Mevastatin is a selective inhibitor of 3-hydroxy 3-methyl glutaryl coenzyme(A) reductase (HMG-CoA reductase), a major enzyme involved in cholesterol synthesis. It acts as a cholesterol-lowering agent. Mevastatin is obtained from various species of fungi. It acts as an antiresorptive agent and has therapeutic effects to treat osteoporosis. Mevastatin inhibits bone resorption by triggering osteoclast apoptosis. It is also involved in the inhibition of prenylation of proteins such as Ras. Mevastatin increases endothelial nitric oxide synthase (eNOS) mRNA and protein levels by blocking the geranylgeranylation of transcription factor Rho. |
| Features and Benefits: | This compound was developed by Daiichi-Sankyo . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Chemical structure: statin |
| General description: | Mevastatin is a polyketide that belongs to the class of statins. It contains a hydroxy-hexahydronaphthal |
| Packaging: | Bottomless glass bottle. Contents are inside inserted fused cone. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| mp | 151 °C |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

